This Week in Addiction Medicine from ASAM
By American Society of Addiction Medicine
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 100
Description
An audio source and summary of the top stories from the field of addiction medicine.
| Episode | Date |
|---|---|
|
Lead: The IARC Perspective on the Effects of Policies on Reducing Alcohol Consumption
|
May 13, 2025 |
|
Lead: Building Multidisciplinary Consensus on Inpatient Xylazine Management through Clinical Protocols
|
May 06, 2025 |
|
Lead: Varenicline for Youth Nicotine Vaping Cessation: A Randomized Clinical Trial
|
Apr 29, 2025 |
|
Lead: Comprehensive drug policies increase trust in local government: an analysis of authorities’ and residents’ perspectives in rural US Appalachian and Midwestern counties
|
Apr 22, 2025 |
|
Lead: Hospital Addiction Consultation Service and Opioid Use Disorder Treatment
|
Apr 15, 2025 |
|
Lead: Averted lung cancer deaths due to reductions in cigarette smoking in the United States, 1970–2022
|
Apr 08, 2025 |
|
Lead: Prescription Stimulant Use, Misuse, and Use Disorder Among US Adults Aged 18 to 64 Years
|
Apr 01, 2025 |
|
Lead: Alcohol Use Disorder Medication Coverage and Utilization Management in Medicaid Managed Care Plans
|
Mar 25, 2025 |
|
Lead: Association Between Telehealth Initiation Of Stimulant Therapy And New Substance Use Disorder Diagnoses
|
Mar 18, 2025 |
|
Lead: The association between buprenorphine doses above 16 milligrams and treatment retention in a multi-payer national sample in the United States, 2014 to 2021
|
Mar 11, 2025 |
|
Lead: Illicit Substance Use and Treatment Access Among Adults Experiencing Homelessness
|
Mar 04, 2025 |
|
Lead: Once-Weekly Semaglutide in Adults With Alcohol Use Disorder
|
Feb 25, 2025 |
|
Lead: Cannabis Use Disorder Emergency Department Visits and Hospitalizations and 5-Year Mortality
|
Feb 19, 2025 |
|
Lead: Real-Time Assessment of Alcohol Reward, Stimulation, and Negative Affect in Individuals With and Without Alcohol Use Disorder and Depressive Disorders
|
Feb 11, 2025 |
|
Lead: Outpatient Low-Dose Initiation of Buprenorphine for People Using Fentanyl
|
Feb 04, 2025 |
|
Lead: Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning
|
Jan 28, 2025 |
|
Lead: Current Advances in Behavioral Addictions: From Fundamental Research to Clinical Practice
|
Jan 21, 2025 |
|
ASAM Weekly Special Episode: Dr. David Fiellin & Dr. Eric Strain sit down to discuss the concept of Treatment Refractory Addiction
|
Jan 14, 2025 |
|
Lead: Review of Evidence on Alcohol and Health
|
Jan 14, 2025 |
|
Lead: The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies
|
Dec 17, 2024 |
|
Lead: Prevalence of pharmacotherapy for attention-deficit/hyperactivity disorder and prescription stimulant misuse: A national study of US college students
|
Dec 10, 2024 |
|
Lead: Xylazine Pharmacokinetics in Patients Testing Positive for Fentanyl and Xylazine
|
Dec 04, 2024 |
|
Lead: Suicide in people prescribed opioid-agonist therapy in Scotland, United Kingdom, 2011–2020: A national retrospective cohort study
|
Nov 19, 2024 |
|
Lead: Links between adolescent binge drinking and midlife alcohol use behaviors by age, sex, and race/ethnicity
|
Nov 05, 2024 |
|
Lead: Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder
|
Oct 29, 2024 |
|
Lead: Association of Daily Doses of Buprenorphine With Urgent Health Care Utilization
|
Oct 22, 2024 |
|
Lead: Facilitators of and barriers to buprenorphine initiation in the emergency department: a scoping review
|
Oct 15, 2024 |
|
Lead: Cannabis Policy Impacts Public Health and Health Equity
|
Oct 08, 2024 |
|
ASAM Weekly Special Episode: Dr. Shannon Miller talks PAM-7 and his path to addiction medicine [From the ASAM 55th Annual Conference]
|
Sep 30, 2024 |
|
Lead: Risk of Incident Psychosis and Mania With Prescription Amphetamines
|
Sep 24, 2024 |
|
Lead: Cannabis Laws and Utilization of Medications for the Treatment of Mental Health Disorders
|
Sep 17, 2024 |
|
Lead: State-level racial and ethnic disparities in buprenorphine treatment duration in the United States
|
Sep 10, 2024 |
|
Lead: Virtual reality-based Mindfulness-Oriented Recovery Enhancement (MORE-VR) as an adjunct to medications for opioid use disorder: a Phase 1 trial
|
Sep 04, 2024 |
|
Lead: The Lancet Psychiatry Commission on youth mental health
|
Aug 27, 2024 |
|
Lead: Alcohol Consumption Patterns and Mortality Among Older Adults With Health-Related or Socioeconomic Risk Factors
|
Aug 20, 2024 |
|
Lead: Physician Reluctance to Intervene in Addiction: A Systematic Review
|
Aug 13, 2024 |
|
ASAM Weekly Special Episode: Rapid Initiation of Injection Naltrexone for OUD | Dr. Matisyahu Shulman & Dr. Adam Bisaga
|
Aug 06, 2024 |
|
Lead: Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders
|
Aug 06, 2024 |
|
Lead: Psilocybin desynchronizes the human brain
|
Jul 30, 2024 |
|
Lead: Secondhand Nicotine Absorption From E-Cigarette Vapor vs Tobacco Smoke in Children
|
Jul 23, 2024 |
|
Lead: Benzodiazepine use in relation to long-term dementia risk and imaging markers of neurodegeneration: a population-based study
|
Jul 16, 2024 |
|
Lead: Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial
|
Jul 09, 2024 |
|
Lead: Global status report on alcohol and health and treatment of substance use disorders
|
Jul 02, 2024 |
|
Lead: Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths
|
Jun 25, 2024 |
|
Lead: Piloting a Hospital-Based Rapid Methadone Initiation Protocol for Fentanyl
|
Jun 18, 2024 |
|
Lead: Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population
|
Jun 11, 2024 |
|
Lead: Innovation and adaptation: The rise of a fentanyl smoking culture in San Francisco
|
Jun 04, 2024 |
|
Lead: Rapid Initiation of Injection Naltrexone for Opioid Use Disorder
|
May 28, 2024 |
|
Lead: Burden of Mental Disorders and Suicide Attributable to Childhood Maltreatment
|
May 21, 2024 |
|
Lead: Associations of cannabis use, use frequency, and cannabis use disorder with violent behavior among young adults in the United States
|
May 14, 2024 |
|
Lead: Biomarkers of metal exposure in adolescent e-cigarette users
|
May 07, 2024 |
|
Lead: Association of regular opioid use with incident dementia and neuroimaging markers of brain health in chronic pain patients
|
Apr 30, 2024 |
|
Lead: Preventing deaths after prison release
|
Apr 23, 2024 |
|
Lead: Telling the story of the opioid crisis
|
Apr 16, 2024 |
|
Lead: Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration
|
Apr 09, 2024 |
|
Lead: Epigenome-wide association study on methamphetamine dependence
|
Apr 02, 2024 |
|
Lead: Disposable E-Cigarette Use and Subsequent Use Patterns in Adolescents and Young Adults
|
Mar 26, 2024 |
|
Lead: Adolescent Δ8-THC and Marijuana Use in the US
|
Mar 19, 2024 |
|
Lead: Association of Cannabis Use With Cardiovascular Outcomes Among US Adults
|
Mar 12, 2024 |
|
Lead: Racial and Ethnic Disparities in Geographic Availability of Buprenorphine
|
Mar 05, 2024 |
|
Lead: Smoking changes adaptive immunity with persistent effects
|
Feb 27, 2024 |
|
Lead: Overdose mortality incidence and supervised consumption services
|
Feb 20, 2024 |
|
Lead: Safety of e-cigarettes and nicotine patches as stop-smoking aids in pregnancy
|
Feb 13, 2024 |
|
Lead: Polysubstance mortality trends in White and Black Americans during the opioid epidemic
|
Feb 06, 2024 |
|
Lead: First Trimester Use of Buprenorphine or Methadone
|
Jan 30, 2024 |
|
Lead: Trends in hallucinogen-associated emergency department visits
|
Jan 23, 2024 |
|
Lead: Adolescent Residential Addiction Treatment In The US
|
Jan 17, 2024 |
|
Lead: Benzodiazepine Discontinuation and Mortality
|
Jan 09, 2024 |
|
ASAM Weekly Top 10 Peer reviewed Scientific Publications of 2023
|
Dec 28, 2023 |
|
Lead: Examining the benefit of a higher maintenance dose of extended-release buprenorphine
|
Dec 19, 2023 |
|
Lead: Relationship between alcohol use and firearm-involved suicide
|
Dec 12, 2023 |
|
Lead: Pregnancy and Postpartum Drug Overdose Deaths in the US Before and During the COVID-19 Pandemic
|
Dec 05, 2023 |
|
Lead: 2022 National Survey on Drug Use and Health
|
Nov 28, 2023 |
|
Lead: Fast dopamine increases drug reward
|
Nov 21, 2023 |
|
Lead: Public health approaches to gambling
|
Nov 15, 2023 |
|
Lead: Clinical Practice Guideline on the Management of Stimulant Use Disorder
|
Nov 07, 2023 |
|
Lead: Chronic pain, cannabis legalisation, and cannabis use disorder
|
Oct 31, 2023 |
|
Lead: Xylazine Adulteration of the Heroin–Fentanyl Drug Supply
|
Oct 24, 2023 |
|
Lead: Heterogeneous neuroimaging findings across substance use disorders localize to a common brain network
|
Oct 17, 2023 |
|
Lead: The association between temperature and alcohol- and substance-related disorder hospital visits
|
Oct 10, 2023 |
|
Lead: US tobacco companies selectively disseminated hyper-palatable foods into the US food system
|
Oct 03, 2023 |
|
Lead: America’s Opioid Ecosystem: How Leveraging System Interactions Can Help Curb Addiction, Overdose, and Other Harms
|
Sep 26, 2023 |
|
Lead: Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients
|
Sep 19, 2023 |
|
Lead: Examining sociodemographic correlates of opioid use, misuse, and use disorders in the All of Us Research Program
|
Sep 19, 2023 |
|
Lead: Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US
|
Sep 12, 2023 |
|
Special Episode: ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder
|
Aug 31, 2023 |
|
Lead: Marijuana and hallucinogen use, binge drinking reached historic highs among adults 35 to 50
|
Aug 29, 2023 |
|
Lead: Perceptions of Safety of Daily Cannabis vs Tobacco Smoking and Secondhand Smoke Exposure
|
Aug 22, 2023 |
|
Lead: Alcohol Intake and Blood Pressure Levels
|
Aug 15, 2023 |
|
Special Episode: The Future of Psychedelic Therapy and Addiction Treatment
|
Aug 11, 2023 |
|
Lead: ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder
|
Aug 08, 2023 |
|
Lead: Recommendations for Reducing the Risk of Cannabis Use-Related Adverse Psychosis Outcomes
|
Aug 01, 2023 |
|
Lead: Examining the prevalence of mono-versus polysubstance use in the general population
|
Jul 25, 2023 |
|
Lead: Questioning the Right to Pain Relief and Its Role in the Opioid Epidemic
|
Jul 18, 2023 |
|
Lead: Xylazine effects on opioid-induced brain hypoxia
|
Jul 11, 2023 |
|
Lead: Psychedelics reopen the social reward learning critical period
|
Jul 04, 2023 |
|
Lead: Reduced Stress-Related Neural Network Activity Mediates the Effect of Alcohol on Cardiovascular Risk
|
Jun 27, 2023 |
|
Lead: Signaling-specific inhibition of the CB1 receptor for cannabis use disorder
|
Jun 20, 2023 |
|
Lead: Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
|
Jun 13, 2023 |
|
Special Episode: Why Patients Transition Off Methadone
|
Jun 09, 2023 |